loadpatents
name:-0.016239166259766
name:-0.016525983810425
name:-0.0050618648529053
Akashi; Koichi Patent Filings

Akashi; Koichi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Akashi; Koichi.The latest application filed is for "method and kit for predicting therapeutic effectiveness of chemotherapy for diffuse large b-cell lymphoma patients".

Company Profile
2.16.12
  • Akashi; Koichi - Fukuoka-shi Fukuoka
  • Akashi; Koichi - Fukuoka JP
  • Akashi; Koichi - Palo Alto CA
  • Akashi; Koichi - Boston MA
  • Akashi; Koichi - Chestnut Hill MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method And Kit For Predicting Therapeutic Effectiveness Of Chemotherapy For Diffuse Large B-cell Lymphoma Patients
App 20200270703 - Miyawaki; Kohta ;   et al.
2020-08-27
Anti-TIM-3 antibody
Grant 10,550,181 - Takayanagi , et al. Fe
2020-02-04
Method for treatment of blood tumor using anti-TIM-3 antibody
Grant 9,958,446 - Takayanagi , et al. May 1, 2
2018-05-01
Anti-tim-3 Antibody
App 20170088616 - TAKAYANAGI; Shin-ichiro ;   et al.
2017-03-30
Anti-TIM-3 antibody
Grant 9,556,270 - Takayanagi , et al. January 31, 2
2017-01-31
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody
App 20160363595 - TAKAYANAGI; Shinichiro ;   et al.
2016-12-15
Method for treatment of blood tumor using anti-TIM-3 antibody
Grant 9,487,591 - Takayanagi , et al. November 8, 2
2016-11-08
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody
App 20150284468 - TAKAYANAGI; Shinichiro ;   et al.
2015-10-08
Method for treatment of blood tumor using anti-TIM-3 antibody
Grant 9,103,832 - Takayanagi , et al. August 11, 2
2015-08-11
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody
App 20140134639 - TAKAYANAGI; Shinichiro ;   et al.
2014-05-15
Anti-tim-3 Antibody
App 20140044728 - TAKAYANAGI; Shin-ichiro ;   et al.
2014-02-13
Method for treatment of blood tumor using anti-TIM-3 antibody
Grant 8,647,623 - Takayanagi , et al. February 11, 2
2014-02-11
Anti-TIM-3 antibody
Grant 8,552,156 - Takayanagi , et al. October 8, 2
2013-10-08
Anti-tim-3 Antibody
App 20120189617 - TAKAYANAGI; Shin-ichiro ;   et al.
2012-07-26
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody
App 20120100131 - Takayanagi; Shinichiro ;   et al.
2012-04-26
Mammalian myeloid progenitor cell subsets
Grant 7,618,654 - Weissman , et al. November 17, 2
2009-11-17
Mammalian Myeloid Progenitor Cell Subsets
App 20080131408 - Weissman; Irving L. ;   et al.
2008-06-05
Mammalian myeloid progenitor cell subsets
Grant 7,300,760 - Weissman , et al. November 27, 2
2007-11-27
Mammalian common lymphoid progenitor cell
Grant 7,297,329 - Akashi , et al. November 20, 2
2007-11-20
Mammalian common lymphoid progenitor cell
App 20050191284 - Akashi, Koichi ;   et al.
2005-09-01
Mammalian common lymphoid progenitor cell
Grant 6,908,763 - Akashi , et al. June 21, 2
2005-06-21
Mammalian myeloid progenitor cell subsets
Grant 6,761,883 - Weissman , et al. July 13, 2
2004-07-13
Mammalian myeloid progenitor cell subsets
App 20040132186 - Weissman, Irving L. ;   et al.
2004-07-08
Mammalian myeloid progenitor cell subsets
Grant 6,465,247 - Weissman , et al. October 15, 2
2002-10-15
Mammalian myeloid progenitor cell subsets
App 20020086422 - Weissman, Irving L. ;   et al.
2002-07-04
Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker
Grant 5,821,108 - Akashi , et al. October 13, 1
1998-10-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed